中国临床药理学杂志
中國臨床藥理學雜誌
중국림상약이학잡지
THE CHINESE JOURNAL OF CLINICAL PHARMACOLOGY
2015年
8期
673-676
,共4页
动脉粥样硬化%表观遗传%组蛋白修饰
動脈粥樣硬化%錶觀遺傳%組蛋白脩飾
동맥죽양경화%표관유전%조단백수식
atherosclerosis%epigenetics%histone modification
动脉粥样硬化是环境因素与遗传因素相互作用所致的慢性炎症疾病。表观遗传因素参与了动脉粥样硬化的发生发展,表观遗传学是指非基因序列改变所致基因表达的变化。组蛋白修饰是表观遗传调控机制之一,组蛋白修饰异常与动脉粥样硬化发病关系密切。本文综述了组蛋白修饰在动脉粥样硬化中作用的研究进展,探讨组蛋白修饰酶作为动脉粥样硬化的治疗手段和靶点的可行性及存在的问题。
動脈粥樣硬化是環境因素與遺傳因素相互作用所緻的慢性炎癥疾病。錶觀遺傳因素參與瞭動脈粥樣硬化的髮生髮展,錶觀遺傳學是指非基因序列改變所緻基因錶達的變化。組蛋白脩飾是錶觀遺傳調控機製之一,組蛋白脩飾異常與動脈粥樣硬化髮病關繫密切。本文綜述瞭組蛋白脩飾在動脈粥樣硬化中作用的研究進展,探討組蛋白脩飾酶作為動脈粥樣硬化的治療手段和靶點的可行性及存在的問題。
동맥죽양경화시배경인소여유전인소상호작용소치적만성염증질병。표관유전인소삼여료동맥죽양경화적발생발전,표관유전학시지비기인서렬개변소치기인표체적변화。조단백수식시표관유전조공궤제지일,조단백수식이상여동맥죽양경화발병관계밀절。본문종술료조단백수식재동맥죽양경화중작용적연구진전,탐토조단백수식매작위동맥죽양경화적치료수단화파점적가행성급존재적문제。
Atherosclerosis is a chronic inflammatory disease of large and medium sized arteries which is caused by environmental and genetic in-teractions.Recently, epigenetic modification of the genome has been identified to play a major role in the disease development .Epigenetics refer to heritable alterations that are not due to changes in DNA sequence and histone modification is one of them .Histone modification is closely related with atherosclerosis .This paper reviewed the histone modification progress in atherosclerosis research , to investigate the feasibility of his-tone modifying enzymes as therapeutic targets of atherosclerosis treat-ment.